Target intelligence / Profile preview

Luminal toxins and harmful substances in the gastrointestinal tract

Molecular classification
Bacterial toxins, Metabolites, Exogenous chemicals, Other
01

Overview

Luminal toxins and harmful substances in the gastrointestinal tract encompass a diverse array of pathogenic molecules and metabolic waste products found within the gut interior. This category includes bacterial exotoxins (e.g., Clostridioides difficile toxins A and B), endogenous metabolites like bile acids, and exogenous harmful agents such as heavy metals or ingested poisons (StatPearls, 2023). These substances contribute to disease by damaging the intestinal epithelial lining, triggering inflammatory responses, or causing systemic toxicity upon absorption (PubMed, PMID: 31430948). Therapeutic management typically involves the use of oral adsorbents, such as activated charcoal, or specific sequestrants like bile acid binders that physically trap these substances to facilitate their fecal excretion (Mayo Clinic, 2024). In specific cases, targeted therapies like monoclonal antibodies are employed to neutralize specific toxins, thereby preventing their cytotoxic effects on the host (NEJM, 2017).

Other names
GI luminal toxinsIntestinal toxinsEnteric toxinsHarmful luminal substancesGastrointestinal luminal contents
02

Mechanism of action

Drugs targeting these substances primarily act through physical adsorption, chemical sequestration (binding), or immunological neutralization to prevent the substances from interacting with the intestinal mucosa or being absorbed systemically (StatPearls, 2023; FDA, 2016).

03

Biological functions

PathogenesisInduction of inflammationDisruption of epithelial barrierMetabolic waste excretion
04

Disease associations

InfectionDiarrheaCholestasisPoisoningChronic kidney disease
05

Safety considerations

Malabsorption of fat-soluble vitaminsNon-specific drug-drug interactionsConstipationBowel obstructionElectrolyte imbalance
06

Interacting drugs

Activated charcoal

6 more in the full profile.

07

Biomarkers

Fecal Clostridioides difficile toxin A/BSerum bile acidsBlood urea nitrogenStool electrolytesFecal calprotectin

Beyond the preview

Go deeper on Luminal toxins and harmful substances in the gastrointestinal tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminal toxins and harmful substances in the gastrointestinal tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call